14 October 2022
26 August 2022
Theramex firmly believes that a national formulary for hormone replacement therapy (HRT) is imperative to allowing more women in the UK access to available HRT products. A national HRT formulary would allow doctors and pharmacists to prescribe any approved medicines for HRT, reducing bureaucracy for local healthcare professionals, as well as cutting down the amount of time women have to wait to access these treatments.
The introduction of a national HRT formulary is also supported by the British Menopause Society and would help to tackle the ongoing HRT supply shortages the UK is currently facing. It would also help address the regional variation in the types of available HRT products which results in inequity in access to products in different areas of the UK.
We strongly support any initiative that gives women greater choice and access to approved medicines for HRT and look forward to working with individuals and organisations across the system to ensure all women receive the best possible care.
All currently available Theramex HRT products remain fully in stock.